RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC).

Source:http://linkedlifedata.com/resource/pubmed/id/21054478

Download in:

View as

General Info

PMID
21054478